Anti-NMDA receptor encephalitis classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
==Classification== | ==Classification== | ||
Anti NMDA Encephalitis may be classified into three subtypes, depending on the timing of presentation and duration. | |||
{| class="wikitable" | |||
|- | |||
! Subtype | |||
! Symptoms | |||
! Duration | |||
|- | |||
| Class 1 | |||
| Primarily by a catatonic or stuporous state | |||
| Less than 60 days | |||
|- | |||
| Class 2 | |||
| Primarily psychotic state | |||
| More than 60 days | |||
|- | |||
| Class 3 | |||
| Primarily catatonic or stuporous | |||
| More than 60 days | |||
|} | |||
==References== | ==References== | ||
Revision as of 01:45, 1 January 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis classification On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis classification |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; AE Dheeraj Makkar, M.D.[2]
Overview
Classification
Anti NMDA Encephalitis may be classified into three subtypes, depending on the timing of presentation and duration.
| Subtype | Symptoms | Duration |
|---|---|---|
| Class 1 | Primarily by a catatonic or stuporous state | Less than 60 days |
| Class 2 | Primarily psychotic state | More than 60 days |
| Class 3 | Primarily catatonic or stuporous | More than 60 days |